Case Studies

  1. Fast Data Insights Improve Productivity, Client Centricity 7/20/2023

    Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.

  2. Validating New Identification Algorithms With Objective Criteria & Clinical Trial Data 7/19/2023

    Learn how researchers and clinicians can make better-informed decisions to advance patient care and enhance public health outcomes related to myocardial infarction.

  3. Shorten The Path: From Discovery To Approval Of Novel Therapies 6/19/2023

    Unearth how this trial design solution was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

  4. Eliminating The Guesswork From Critical Decision Making 6/19/2023

    By leveraging a unified platform, see how this sponsor was able to overcome the logistical complexities of patient randomization, streamlining, and condensing processes.

  5. Automated Trial Monitoring Workflows Make Small Teams More Efficient 4/13/2023

    A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.

  6. How To Double High-Performing Site Count In A Priority Indication 3/13/2023

    A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.

  7. Imunon Phase IB Ovarian Cancer Study Shows Strong Progression-Free Survival Treatment Effect Using A Synthetic Control Arm 12/8/2022

    Explore how Imunon used a control arm among stage III/IV ovarian cancer patients in their clinical trial.

  8. A Mid-Sized Sponsor Increased Site Count By 50% In A Rare Disease Clinical Trial 12/8/2022

    In this case study, explore how a mid-sized sponsor chose high-performing sites based on reliable data to set their trial up for success.

  9. Medicenna Gains Precedent-Setting FDA Approval 12/8/2022

    Learn how Medicenna was able to leverage Synthetic Control Arm (SCA) to bolster Phase 2 findings and gain FDA approval to design a hybrid external control arm for their Phase 3 registrational trial.

  10. Predictors Of Severe CRS In Longitudinal CAR T-Cell Clinical Trial Data 9/15/2022

    Find out how laboratory tests were analyzed with repeated measurements to identify differences in trends that persist across a variety of study designs, sponsors, and indications.